CDCA2 and melanoma: In addition to previous studies that reported CDCA2 up-regulation in aggressive neuroblastoma, melanoma, and breast cancer [11], [14], [15], we found significant up-regulation of CDCA2 in the OSCC cell lines compared with that in the HNOKs.